mrna

Moderna reports a loss in its second quarter; the traditional market reaction is intense. NBIX plunges 10%, while MRNA falls 3.6%. The halo around mRNA technology is fading, and the single-shot vaccine story is becoming harder to tell. Funds are starting to withdraw from the biotech sector— is this just the beginning, or an overreaction? Watch for subsequent pipeline progress and share repurchase moves.

#美股 #生物科技 #MRNA

$MRNA HIGHER LOWS CONFIRM BUYERS STILL IN CONTROL 🔥

Entry: $79.80–$80.60 🔥
Target: $83.00 / $86.00 / $90.00 🚀
Stop Loss: $77.50 ⚠️

The pattern of higher lows on the 1H chart is intact, and price is now testing the lower end of a support zone that has held twice this week. Momentum indicators show buying pressure rising on each retracement, suggesting accumulation. The defined risk at $77.50 keeps this setup attractive with multiple targets above for partial profit-taking.

What level are you watching to confirm the next leg up?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #Momentum

🔥

$MRNA PRICE TARGET RAISED TO $60 BY JPMORGAN 🔥

JPMorgan just lifted Moderna’s price target from $53 to $60 — a clear vote of confidence from one of the biggest banks on the Street. That’s a 13% upside from the old target, and this kind of institutional upgrade tends to attract follow-through buying in the days ahead.

The question is whether this is the start of a stronger trend or just a one-off analyst bump. Are you adding to your position or waiting for price action to confirm?

Not financial advice. Always manage your risk.

#MRNA #PriceTarget #Bullish #Upgrade #Biotech

🔥

#ModernaRisesOver12%
Moderna (MRNA) shares shot up more than 12% yesterday, closing at about $67.

Why the big jump?

> The company shared exciting updates on new mRNA treatments for cancer prevention, autoimmune diseases and more.
> Good news from the FDA on their flu vaccine also helped boost confidence.

This is a big win for the biotech company, which has been working hard to expand beyond COVID vaccines. Investors are feeling optimistic about the future!

What do you think — is this the start of something bigger for Moderna?
#Moderna #Stocks #MRNA

$MRNA IS TESTING A TIGHT ENTRY ZONE WITH A CLEAR TARGET SETUP 🔥

Entry: 79.80–80.60 🔥
Target: 83.00 🚀
Stop Loss: 77.50 ⚠️

This range has been holding as a solid bid zone over the last few sessions. Risk is defined just below 77.50, giving you a clean 1:1.5 reward potential if that first target gets tagged.

Volume is starting to pick up on the shorter timeframes, and the last time we saw this pattern, price ran past the first target within hours. Are you stepping in here or waiting for a retest of the lower end?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #Trading

🔥

$MRNA SHOWING CLASSIC BREAK AND RETEST PATTERN AT SUPPORT 🔥

Entry: $79.80 - $80.60 🔥
Target: $83.00 🚀
Target: $86.00 🚀
Target: $90.00 🚀
Stop Loss: $77.50 ⚠️

Price is consolidating just above a key order block that has triggered aggressive buying in previous sessions. The 4H chart shows a sharp V-recovery off the $79 handle with increasing volume on the retest — a clear sign of institutional interest absorbing supply. The risk to reward on the first target alone sits above 1:2, making this a mechanically sound swing setup.

Are you entering at this zone or waiting for confirmation above $81?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #BiotechLabs

🔥

$MRNA IS PRINTING HIGHER LOWS AT A KEY SUPPORT ZONE 🔥

Entry: $79.80–$80.60 🔥
Target: $83.00 🚀
Stop Loss: $77.50 ⚠️

Bids are stepping in every time price dips into this $80 area. The last three hourly closes sit above $80.20 with decreasing lower wicks — that tells me sellers are losing steam and buyers are absorbing supply.

Volume is also picking up on the 15-minute chart as we grind higher from the intraday low. If $82 breaks clean, $83 is in play fast. What's your move — buy the dip or wait for a breakout?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #Crypto

🔥

$MRNA SHOWING STRONG BULLISH RECOVERY AT SUPPORT – BREAKOUT IMMINENT 🔥

Entry: 80.00 - 80.50 🔥
Target: 85.00 🚀
Stop Loss: 77.50 ⚠️

Price is consolidating near resistance after a clean bounce from the demand zone. Buyers are holding the higher structure, and the three-target layout confirms institutional intent. Volume is picking up on the shorter timeframes — a breakout above 81.50 could trigger the next leg toward 85.00.

Are you entering at current levels or waiting for a sweep of 80.00 first?

Not financial advice. Always manage your risk.

#MRNA #BullishRecovery #Breakout #LongSetup

🔥

📈 #ModernaRisesOver12% — Biotech Giant Surges on New Pipeline Data

Moderna shares jumping over 12% after positive clinical trial data for its next-generation mRNA vaccine pipeline. Investors piling back into biotech as Moderna demonstrates progress beyond COVID-19 vaccines.

#ModernaRisesOver12% #Biotech #MRNA

$MRNA IS HOLDING SUPPORT AND EYEING A BREAKOUT CONTINUATION 🔥

Entry: $80.00–$80.50 🔥
Target: $81.50 🚀
Stop Loss: $77.50 ⚠️

Buyers stepped in right at the support zone and the price is now consolidating near resistance for the second time today. The bounce was sharp — volume picked up immediately as the level held. If this consolidation breaks to the upside, momentum should carry it toward the next target.

The move higher has been clean so far and the structure is still intact. Are you watching this level for an entry or waiting for a retest?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #BullishRecovery

💎

$MRNA IS PRIMED FOR A LIQUIDITY SWEEP TOWARD $88 🔥

Entry: 79.80 🔥
Target: 88.00 🚀
Stop Loss: 77.90 ⚠️

The entry zone at 79.80-80.60 sits just above a clear stop-loss cluster at 77.90. This creates a tight risk window with a reward of nearly 10% to the final target. The defined structure gives a risk-to-reward ratio above 1:4, which is uncommon for a mid-cap setup.

Volume has been climbing on the lower timeframes as price approaches this demand area. The momentum suggests a quick reaction if the zone holds. Are you fading the break or waiting for a clean reclaim?

Not financial advice. Always manage your risk.

#MRNA #LongSetup #Breakout #Crypto

🔥

$MRNA JPMORGAN RAISES PRICE TARGET TO $60 🎯

JPMorgan's upgrade of Moderna's target from $53 to $60 reflects a 13% upside conviction that aligns with increasing volume in the biotech space. This institutional nod often precedes structural breaks on the daily chart, especially after a period of consolidation near the $55 resistance zone.

Are you positioning ahead of the next catalyst or waiting for a cleaner entry?

Not financial advice. Always manage your risk.

#MRNA #PriceTarget #Bullish #Biotech #Upgrade

🎯

#ModernaRisesOver12%
​Moderna Inc. $MRNAon ignited the stock market with a massive rally, surging over 12% to hit a brand new 52-week high near $67.80. This powerful momentum comes as a relief to investors, marking a stellar year-to-date gain of over 100% from its deep lows.
​The primary catalyst? Wall Street is officially cheering Moderna’s deep clinical pipeline that goes far beyond COVID-19. Investors reacted heavily to the company’s recent "Science Day" presentation, which showcased groundbreaking advancements in mRNA-based cancer antigen therapies and autoimmune treatments. Furthermore, an FDA advisory panel recently voted a unanimous 9-0 in favor of Moderna’s new seasonal flu vaccine (mRNA-1010), setting up a massive catalyst for official approval this August.
​As capital rotates from volatile tech and chip stocks into high-potential healthcare names, top institutional firms like Piper Sandler have promptly raised their price targets to $77. Tech indicators show strong bullish momentum, proving that Moderna’s transformation into a diversified biotech giant is fully underway.
​#ModernaRisesOver12% #StockMarketNews #Biotech #Investing #MRNA #mRNA #FinanceUpdate #WallStreet

$MRNAon is holding a strong demand zone after a healthy consolidation following an impulsive move higher. Price continues to print higher lows above the rising moving averages, while support around the 79.7–80.0 area is being defended. A push through the recent intraday highs could open the door for another expansion if buying pressure remains steady.

Long Setup

Entry: $80.20–$80.60
Stop Loss: $79.10
Targets: $81.30 | $82.50 | $84.00

Wait for confirmation before entering. If buyers maintain momentum and price breaks above the recent resistance with conviction, the next leg higher could develop quickly. #MRNA

#modernarisesover12% 🚀 $MRNAon
Breaking Out! 🔥
$MRNA surged 12%+ after strong bullish catalysts: ✅ FDA panel backs its mRNA flu vaccine ✅ Analysts raise target to $77 ✅ Pipeline momentum remains strong
📈 Smart move: Wait for a healthy pullback instead of chasing the pump.
Are you bullish on $MRNAon ? 👇
#MRNA #Moderna #Biotech

【Earnings Season “Crash” Scene】

The traditional pharmaceutical sector has been a bit chilly lately.

Moderna (MRNA) turned in a second-quarter loss performance, and the market clearly isn’t buying it—its share price immediately dropped 3.6%. Even worse, the biotech company Neurocrine Biosciences (NBIX) plunged 10% in a single day, dragging market sentiment down with it.

Some are happy, others are not:

- Losses widened vs. expectations, and the vaccine leader halo faded
- NBIX’s decline was even steeper, weighing on sector sentiment
- Earnings season is often a critical moment to test a company’s true quality

When results miss expectations, it’s easy for the stock to “vote with its feet.” This also reminds us that volatility during the traditional market’s earnings season isn’t small. Whether or not you trade related instruments, it’s worth paying attention to how macro sentiment filters through.

#美股财报 #生物医药板块 #MRNA

🚨 THEY PATENTED REMOTE CONTROL OF YOUR BODY 🚨
Rockefeller University patent US10786570B2:
Inject ferritin nanoparticles (or mRNA that makes your cells produce them). They attach to your cell membranes like tiny antennas.
Then a phone, wearable or tower blasts 465 kHz radio waves… and your own cells heat up → calcium floods in → massive hormone dumps on demand.
Insulin. Adrenaline. Cortisol. Dopamine. Even brain firing.
They can crank your emotions, heart, and mind like a TV remote.
This ain’t sci-fi. It’s patented.
Wake up before it’s too late. 😱
#RemoteControl #WakeUp #Ferritin #mRNA #BigPharma #TheyOwnYou
$BSB $AIN $LDO

🚀 $MRNA Showing Strong Bullish Momentum! 👀

$MRNA continues to print higher lows, suggesting buyers are still defending the trend.

🟢 Trade Idea: Long
📍 Entry: $79.80 – $80.60
🛑 Stop Loss: $77.50
🎯 TP1: $83.00
🎯 TP2: $86.00
🎯 TP3: $90.00

If buying pressure remains strong, the price could continue toward the next resistance levels. Always wait for confirmation and manage your risk before entering any trade. ⚠️📊

💬 What's your view on $MRNA?
🚀 Bullish continuation or 📉 pullback first? Share your thoughts below!

#MRNA #CryptoTrading #BinanceSquareFamily #TradingStrategy #MarketAnalysis